Robert Ainscow
Fondatore presso ASP ISOTOPES INC.
Patrimonio netto: 3 M $ in data 30/06/2024
Provenienza dei contatti di primo grado di Robert Ainscow
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Unknown | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Robert Ainscow tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
PROCTER & GAMBLE COMPANY | Household/Personal Care | Chief Tech/Sci/R&D Officer | |
ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Soros Fund Management LLC
Soros Fund Management LLC Investment ManagersFinance Soros Fund Management LLC (SFM) is a privately-held investment management firm now structured as a family office, but which was once a hedge fund manager. The firm was founded in 1969 and is headquartered in New York City. SFM serves as the principal asset manager for the Open Society Foundations (Open Society) – a private funder of independent groups that works for justice, democratic governance, and human rights. | Investment Managers | Analyst-Equity Analyst-Equity | |
Highbridge Capital Management LLC
Highbridge Capital Management LLC Investment ManagersFinance Highbridge Capital Management LLC (HCM Highbridge is a registered investment advisor and global alternative investment firm headquartered in New York City. The firm was founded in 1992 and is a subsidiary of JPMorgan Asset Management Holdings Inc., which is a wholly-owned subsidiary of JPMorgan Chase & Co. (NYSE: JPM). Highbridge manages capital for sophisticated investors, who include financial institutions, public and corporate pension funds, sovereign wealth funds, endowments and family offices. | Investment Managers | Corporate Officer/Principal | |
University of KwaZulu-Natal | College/University | Doctorate Degree | |
LYONDELLBASELL INDUSTRIES N.V. | Chemicals: Specialty | Corporate Officer/Principal | |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
REGENETP, INC. | Biotechnology | Director of Finance/CFO | |
University of Oxford | College/University | Doctorate Degree | |
University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
University of Leeds | College/University | Undergraduate Degree | |
Deutsche Bank AG (Broker UK)
Deutsche Bank AG (Broker UK) Investment Banks/BrokersFinance Deutsche Bank AG (Deutsche Bank UK) is the UK-based securities brokerage division of Deutsche Bank AG (ETR: DBK) in Germany. The firm is headquartered in London and was founded in 1873. Deutsche Bank provides brokerage services to companies and institutions. | Investment Banks/Brokers | Analyst-Equity | |
Rutgers State University of New Jersey | College/University | Masters Business Admin | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Pretoria | College/University | Undergraduate Degree | |
Morgan Stanley & Co. International Plc
Morgan Stanley & Co. International Plc Investment Banks/BrokersFinance Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Nelson Mandela Metropolitan University | College/University | Graduate Degree | |
Novosibirsk State University | College/University | Graduate Degree | |
SIBUR Holding JSC
SIBUR Holding JSC Oil Refining/MarketingEnergy Minerals SIBUR Holding JSC engages in the production and market of energy and petrochemical products. It operates through the following segments: Olefins and Polyolefins, and Plastics, Elastomers, and Intermediates. The Olefins and Polyolefins segment produces polypropylene, polyethylene, propylene, and ethylene. The Plastics, Elastomers, and Intermediates segment focuses on the production of synthetic rubbers, plastics, organic synthesis products, and other petrochemical products. The company was founded in 1995 and is headquartered in Moscow, Russia. | Oil Refining/Marketing | Director/Board Member | |
HEALTHTECH SOLUTIONS INC. | Packaged Software | Chairman | |
EuroChem Mineral & Chemical Co. OJSC
EuroChem Mineral & Chemical Co. OJSC Chemicals: AgriculturalProcess Industries EuroChem Mineral & Chemical Co. OJSC manufactures and distributes chemical products. It offers nitrogen, phosphate, and biological fertilizers, feed phosphates, as well as other agricultural chemicals. The company was founded by Nikolay Valentinovich Levitskiy on August 27, 2001 and is headquartered in Moscow, Russia. | Chemicals: Agricultural | Director/Board Member | |
East West Capital Partners Pte Ltd.
East West Capital Partners Pte Ltd. Investment ManagersFinance East West Capital Partners Pte Ltd (East West Capital Partners) is a Private Equity firm founded in 2005 by Sanjay K Sehgal. The firm is headquartered in Singapore. | Investment Managers | Private Equity Investor | |
Lamellar Biomedical Ltd.
Lamellar Biomedical Ltd. Pharmaceuticals: MajorHealth Technology Lamellar Biomedical Ltd. manufactures basic pharmaceutical products. The firm's offers lamellasomes, a synthetic substance that mimics the actions lamellar bodies and provides treatment for respiratory diseases, such as cystic fibrosis. The company was founded in 2006 and is headquartered in Bellshill, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Klydon Pty Ltd. | Chief Executive Officer | ||
South African Atomic Energy Corp. | Chief Tech/Sci/R&D Officer | ||
SFM UK Management LLP
SFM UK Management LLP Investment ManagersFinance SFM UK Management LLP (SFM UK) is the Great Britain-based alternative investment subsidiary of Soros Fund Management LLC in the US. Headquartered in London, SFM UK was founded in 2008 and manages assets of high net worth clients. | Investment Managers | Analyst-Equity | |
UBS AG (Private Banking UK)
UBS AG (Private Banking UK) Investment ManagersFinance UBS AG (Private Banking UK) is the Great Britain-based private banking division of UBS AG (London Branch), ultimately held by UBS Group AG (NYSE: UBS, SWX: UBSG) in Switzerland. Headquartered in London, the firm was founded 1998 and provides a range of private banking services to high-net worth clients. | Investment Managers | Analyst-Equity | |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chairman | |
Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
Braidlock Ltd.
Braidlock Ltd. Medical SpecialtiesHealth Technology Braidlock Ltd. engages in the development and manufacture of medical products. Its products include Braidlock Chevron and Braidlock NG. The company was founded in 2004 and is headquartered in Prestwick, the United Kingdom. | Medical Specialties | Corporate Officer/Principal | |
Castle Hook Partners LP
Castle Hook Partners LP Investment ManagersFinance Castle Hook Partners LP (Castle Hook) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by David Rogers and Joshua Donfeld in 2016. Castle Hook serves as the investment advisor, with discretionary trading authority, to a number of private pooled investment vehicles, the securities of which are offered to qualified investors on a private placement basis. | Investment Managers | Founder | |
GENENTA SCIENCE S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Chairman | |
TARONIS FUELS, INC. | Chemicals: Specialty | Director/Board Member | |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Biotechnology | Chairman Director/Board Member | |
ARYA SCIENCES ACQUISITION CORP IV | Financial Conglomerates | Director/Board Member | |
ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Director/Board Member | |
Xanadu Bio Inc. | Founder |
Statistiche
Distribuzione geografica
Stati Uniti | 22 |
Regno Unito | 14 |
Sud Africa | 6 |
Russia | 3 |
Danimarca | 3 |
Settori
Finance | 18 |
Consumer Services | 12 |
Health Technology | 10 |
Process Industries | 4 |
Technology Services | 3 |
Posizioni
Director/Board Member | 27 |
Independent Dir/Board Member | 15 |
Analyst-Equity | 14 |
Chairman | 13 |
Corporate Officer/Principal | 7 |
Contatti più connessi
Insiders | |
---|---|
Duncan Moore | 19 |
Paul Mann | 17 |
Todd Wider | 15 |
Sergey Vasnetsov | 10 |
Joshua Donfeld | 8 |
Hendrik Strydom | 6 |
Mike Gorley | 2 |
Rob Ryan | 2 |
- Borsa valori
- Insiders
- Robert Ainscow
- Connessioni Società